Rizzi Sergio, Pannone Luigi, Monaco Cinzia, Bisignani Antonio, Miraglia Vincenzo, Gauthey Anais, Bala Gezim, Al Housari Maysam, Lipartiti Felicia, Mojica Joerelle, Del Monte Alvise, Mouram Sahar, Sieira Juan, Ströker Erwin, Almorad Alexandre, Iacopino Saverio, Chierchia Gian Battista, De Asmundis Carlo
Heart Rhythm Management Centre, Postgraduate Course in Cardiac Electrophysiology and Pacing, European Reference Networks Guard-Heart, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium.
J Interv Card Electrophysiol. 2022 Dec;65(3):731-737. doi: 10.1007/s10840-022-01329-3. Epub 2022 Aug 9.
This study aimed to evaluate the feasibility and safety of an innovative "all in one" integrated transseptal crossing device to achieve transseptal puncture (TSP).
Twenty patients (10 males, mean age 65.65 ± 9.25 years), indicated to supraventricular left side tachyarrhythmia ablation, underwent TSP using a new-generation integrated crossing device, and a control cohort of twenty patients (10 males, mean age 65.5 ± 10.12 years) underwent TSP using the traditional TSP system.
In all the study patients, the novel TSP device led to a successful and safe access to the left atrium (LA). The mean transseptal time, defined as the time occurring between the groin puncture and the advancing of the guidewire into the left superior pulmonary vein (PV), was 3 min 33 s ± 44 s, 7 min 5 s ± 36 s in the control cohort. Additionally, we compared the cost of the two systems. No acute complications related to the TSP were noted in both cohorts.
TSP performed with the new integrated transseptal system is feasible and safe.
本研究旨在评估一种创新的“一体化”经间隔穿刺装置实现经间隔穿刺（TSP）的可行性和安全性。
20例（10例男性，平均年龄65.65±9.25岁）因室上性左侧快速心律失常消融而需行经间隔穿刺的患者，使用新一代一体化穿刺装置进行经间隔穿刺，另外20例患者（10例男性，平均年龄65.5±10.12岁）作为对照组，使用传统经间隔穿刺系统进行经间隔穿刺。
在所有研究患者中，新型经间隔穿刺装置成功且安全地进入左心房（LA）。平均经间隔时间定义为从腹股沟穿刺到导丝进入左上肺静脉（PV）的时间，研究组为3分33秒±44秒，对照组为7分5秒±36秒。此外，我们比较了两种系统的成本。两组均未发现与经间隔穿刺相关的急性并发症。
使用新型一体化经间隔系统进行经间隔穿刺是可行且安全的。
